Lion Biotechnologies Inc (NASDAQ:LBIO) Investor Investigation Concerning Possible Wrongdoing

An investigation on behalf of investors in Lion Biotechnologies Inc (NASDAQ:LBIO) shares over potential wrongdoing at Lion Biotechnologies was announced and NASDAQ:LBIO stockholders should contact the Shareholders Foundation.

Logo

San Diego, CA -- (SBWire) -- 06/10/2016 --An investigation on behalf of investors in shares of Lion Biotechnologies Inc (NASDAQ:LBIO) was announced over potential breaches of fiduciary duties by certain officers and directors at Lion Biotechnologies.

Investors who purchased shares of Lion Biotechnologies Inc (NASDAQ:LBIO) and currently hold any of those Lion Biotechnologies shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Lion Biotechnologies officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Shares of Lion Biotechnologies Inc (NASDAQ:LBIO) declined from as high as $13.59 per share in March 2015 to as low as $4.54 per share in March 2016.

On June 8, 2016, NASDAQ:LBIO shares closed at $8.01 per share.

Those who purchased shares of Lion Biotechnologies Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/696895